ArticleIrish journal of medical science2026
Blood glucose and ketone testing practices in acute admissions of patients with diabetes mellitus: A retrospective audit.
Article in Irish journal of medical science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDiabetes mellitus (DM) accounts for approximately 20% of hospital admissions. Admission glucose and ketone testing is essential to detect acute metabolic complications. The Joint British Diabetes Societies for Inpatient Care (JBDS-IP) and the American Diabetes Association (ADA) recommend glucose and ketone testing for all hospitalised diabetic patients. We evaluated testing practices, assessed adherence to recommendations, and explored clinical factors associated with testing.
methodsWe retrospectively reviewed 100 consecutive diabetic patients admitted via the emergency department over three months. Adults aged ≥ 16 years with length of stay (LOS) > 24 h were included. Exclusions were advanced renal failure, pregnancy, severe anaemia, significant blood loss, or haemoglobinopathies. Data were extracted from electronic medical records. Analyses used SPSS v22. Group comparisons used Mann-Whitney U, chi-square, or t-tests. Multiple linear regression assessed factors associated with log-transformed LOS; logistic regression evaluated factors associated with glucose testing.
resultsMedian age was 59.5 years (IQR 13.0); 46% were female. 28% had type 1 and 72% type 2 DM. Glucose was measured on admission in 83% and ketones in 58%. Four patients (4%) with neither developed metabolic acidosis. Patients with type 2 DM were older than type 1 (median 67 vs 42 years, p < 0.001). Median LOS was 8 days (IQR 12.8), with no differences by DM type or sex. Regression models for LOS and glucose testing were not significant.
conclusionAdmission glucose and ketone testing was suboptimal and may contribute to preventable metabolic complications. Education and workflow changes are planned, with a re-audit to evaluate impact.
Indexed as
Identifiers
42635885What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.